Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis C treatment completion in patients on maintenance therapy for opiate dependence
2007-001130-13Phase 4Completed
- Sponsor
- Skåne University Hospital
- Start
- Nov 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of peginterferon alfa-2b + ribavirin in hepatitis C virus infection, sponsored by Skåne University Hospital. Primary endpoint: Treatment completion rate. Started Nov 2007; status: completed.
02
Drugs
peginterferon alfa-2b + ribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2007-001130-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001130-13.